We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Home Test Confirms Men's Post-Vasectomy Sterility

By Biotechdaily staff writers
Posted on 19 Mar 2008
Vasectomies are not 100% effective, and vasectomized men can experience recanalization, or the spontaneous healing or restoration of the vas deferens resulting in fertility. More...
A test has been developed that can be used to monitor and confirm sterility following the vasectomy procedure, alerting couples should fertility become restored. In addition, the device could be used to monitor male infertility over time in the event that male contraceptive pills are successfully developed.

The device gives men an opportunity to test their post vasectomy fertility status at home rather than return to the physician's office or a laboratory with semen samples, as has traditionally been required to confirm sub-fertile sperm levels.

A gene (ACRV1) was identified that encoded a protein that could serve as a sperm-specific biomarker. The SP-10 protein is very soluble and highly expressed, making it an ideal target for diagnostic testing. The new device uses monoclonal antibodies that bind specifically to the SP-10 protein to measure the amount in nanograms of SP-10 protein, which directly correlates to the number of sperm present.

Called SpermCheck Vasectomy, the test was created using technology developed by Professor John C. Herr, director of University of Virginia's Center for Research in Contraceptive and Reproductive Health (Charlottesville, VA, USA). The test been approved by the U.S. Food and Drug Association (FDA; Rockville, MD, USA).

"The SpermCheck Vasectomy test is the result of many years of basic science research coupled with clinical chemistry know-how,” said Prof. Herr. "Similar to a home pregnancy test for women, it is the first immunodiagnostic test with the sensitivity and specificity required to detect low numbers of sperm, and it is the first immunodiagnostic test to receive FDA approval for monitoring sperm count after vasectomy.”


Related Links:
U.S. Food and Drug Association
University of Virginia's Center for Research in Contraceptive and Reproductive Health

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.